Clinicopathological characteristics of gangliogliomas with anaplastic morphology
10.3760/cma.j.cn112151-20231227-00444
- VernacularTitle:具有间变特征的节细胞胶质瘤的病理学特征
- Author:
Linai GUO
1
;
Leiming WANG
;
Yongjuan FU
;
Tao LUO
;
Xiaotong FAN
;
Lihong ZHAO
;
Xiaohong YAO
;
Yueshan PIAO
Author Information
1. 首都医科大学宣武医院病理科 北京市老年病医疗研究中心，北京 100053
- Keywords:
Ganglioglioma;
Anaplasia;
Sequence analysis, DNA;
DNA methylation;
Epilepsy
- From:
Chinese Journal of Pathology
2024;53(6):585-591
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical, radiological, and pathological features of anaplastic gangliogliomas (AGGs) and to determine whether these tumors represent a distinct entity.Methods:Consecutive 667 cases of ganglioglioma (GG) diagnosed at the Xuanwu Hospital, Capital Medical University, Beijing, China between January 2015 and July 2023 were screened. Among these cases, 9 pathologically confirmed AGG cases were identified. Their clinical, radiological, treatment, and outcome data were analyzed retrospectively. Most of the tumor samples were subject to next-generation sequencing, while a subset of them were subject to DNA methylation profiling.Results:Among the 9 patients, there were five males and four females, with a median age of 8 years. Epileptic seizures (5/9) were the most frequently presented symptom. Radiological examinations showed three types of radiological manifestations: four cases showed abnormal MRI signals with no significant mass effects and mild enhancement; two cases demonstrated a mixed solid-cystic density lesion with peritumoral edema, which showed significant heterogeneous enhancement and obvious mass effects, and one case displayed cystic cavity formation with nodules on MRI, which showed evident enhancements. All cases exhibited mutations that were predicted to activate the MAP kinase signaling pathway, including seven with BRAF p.V600E mutation and two with NF1 mutation. Five AGGs with mutations involving the MAP kinase signaling pathway also had concurrent mutations, including three with CDKN2A homozygous deletion, one with a TERT promoter mutation, one with a H3F3A mutation, and one with a PTEN mutation.Conclusions:AGG exhibits a distinct spectrum of pathology, genetic mutations and clinical behaviors, differing from GG. Given these characteristics suggest that AGG may be a distinct tumor type, further expansion of the case series is needed. Therefore, a comprehensive integration of clinical, histological, and molecular analyses is required to correctly diagnose AGG. It will also help guide treatments and prognostication.
